What BIOXHALE LTD does

BIOXHALE LTD (Bioxhale) is a UK-based, privately held diagnostics and breath-analysis company operating in Leicester. The company develops and supplies proprietary breath samplers alongside a portfolio of breath analysis services aimed at non-invasive diagnostics, wellbeing monitoring, and environmental exposure assessment. Its underlying technology is Breathomics — the capture and study of volatile organic compounds (VOCs) in exhaled breath — backed by engineered sampling devices designed for reliable, high-fidelity results in challenging environments, including bio-security at source and protection against external contamination. The services stack applies an Analytical Quality by Design methodology and includes quality assurance, study design and governance, quality control standards, training and proficiency testing, data processing and curation, a breath biomarker repository, and laboratory systems design.

The company serves healthcare providers, clinical and academic researchers, environmental and occupational health organizations, and consumer/wellness buyers seeking non-invasive, repeatable testing. Revenue mechanics span hardware sales of breath samplers, professional services and consultancy, and technology licensing and know-how transfer. Go-to-market is sales-led and relationship-driven, with a contact-form entry point and direct engagement by the leadership team rather than self-serve or channel distribution. The team cites over 20 years of research and delivery spanning Europe, North America, and Asia across conditions including asthma, COPD, cancer, heart failure, COVID-19, pesticide poisoning, radiation exposure, and chlorine exposure. Bioxhale holds no disclosed patents or formal regulatory certifications in the available data, and is actively seeking external investment through a dedicated investor page.

Name

BIOXHALE LTD

Legal name

BIOXHALE LTD

Website

https://bioxhale.com

Company type

Private

Founded year

2013

Operating status

Operating

Headcount range

1–10 employees

Ownership category

akta.pro rank

Product category

Breath Diagnostics

NAICS

Analytical Laboratory Instrument Manufacturing (334516), Medical Laboratories (621511)

SIC

Laboratory Analytical Instruments (3826), Services-Medical Laboratories (8071)

akta.pro primary industry

Pulmonary Function Testing (PFT) & Respiratory Diagnostics (HLAKANAC)

akta.pro secondary industry

Sample Preparation, Storage & Cryogenics (Freezers, Cryovials, Cryostats) (HLAGAIAJ)

Keywords

• Breath diagnostics
• Breath analysis services
• Non-invasive diagnostics
• Respiratory disease detection
• Volatile organic compound analysis

Headquarters

HQ city

Leicester

HQ country

United Kingdom

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales

Revenue model

1. Breath Sampler Products: Sale of proprietary breath sampling devices designed for ease of use, reliability, and reproducibility. Products are described as affordable and recyclable, sold to practitioners and researchers.
2. Breath Analysis Services: Consultancy and service fees covering analytical quality by design, quality assurance, study design and governance, quality control standards, training and proficiency testing, data processing and curation, and laboratory systems and operational design.
3. Technology Licensing and Know-How Transfer: The company shares its know-how with customers through services and consultancy support that reduce costs and timelines for establishing breath-testing operations.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Bioxhale develops and manufactures proprietary breath samplers and provides breath analysis services for non-invasive clinical diagnostics, health monitoring, and environmental exposure assessment. The company delivers sample-to-information breath-testing solutions combining engineered breath-sampler hardware with consultancy services such as quality assurance, study design, data processing, biomarker repository access, and laboratory operational design. Its work centers on Breathomics — the analysis of volatile organic compounds (VOCs) in exhaled breath.

Product overview

BIOXHALE LTD is a healthcare technology company offering a portfolio of breath testing products and services. The core product is their Breath Sampler line, complemented by comprehensive Breath Analysis Services that include quality assurance, study design, training, data processing, biomarker repositories, and laboratory operational design. The company also features a featured product on their homepage. Founded in 2013, the company delivers sample-to-information breath testing solutions for diagnostics, wellbeing, and environmental exposure monitoring.

Differentiator

Problem solved

Functional benefit

Products and services

• Breath Samplers Engineered, easy-to-use breath sampling devices designed to provide reliable, high-fidelity results even in challenging working environments. Intuitive, recyclable, and affordable, with fast sampling, bio-security at source, and protection against external contamination. Targeted at healthcare practitioners, clinical researchers, and environmental/occupational health organizations conducting breath-testing operations.
• Breath Analysis Services Consultancy and analytical services covering quality assurance, study design and governance, quality control standards, training and proficiency tests, data processing and curation, breath biomarker repository access, and laboratory systems and operational design. Aimed at healthcare providers, clinical and academic researchers, and environmental/occupational health organizations seeking to establish or improve breath-testing operations.

Quantifiable outcome

• Ranked No. 3 in Top Ten Emerging Technologies of 2021
• +1 more outcomes

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Breathomix: Netherlands-based developer of eNose (SpiroNose) breath analysis technology for clinical diagnostics including lung cancer, COPD, asthma, and COVID-19. Directly comparable to Bioxhale in applying exhaled-breath analysis to respiratory and broader disease detection.
• Owlstone Medical: Cambridge, UK-based breath biopsy company developing breath-based diagnostics for cancer, inflammatory disease, and infectious disease. Direct competitor to Bioxhale in the same breathomics category, with a similar B2B model targeting pharma and clinical research customers.
• Bedfont Scientific: UK-based manufacturer of breath gas monitors (NO, CO, H2, methane) used in clinical and occupational health settings. Comparable to Bioxhale as a UK-headquartered breath analysis hardware and consumables business serving healthcare providers.
• Menssana Research: US-based developer of breath diagnostics for lung cancer, breast cancer, and other diseases, with proprietary breath collection and analysis workflows. Closely comparable to Bioxhale in its research-grade breathomics platform and biomarker discovery approach.

Emerging players

• Avisa Diagnostics: US-based company developing breath-based detection of bacterial infection in the lung using a proprietary substrate and UV spectroscopy. Comparable to Bioxhale as a non-invasive breath-based diagnostic platform targeting serious respiratory and infectious disease.
• Applied Nanodetectors: UK-based developer of nanodetector sensor technology for breath analysis, including volatile organic compound detection. Directly comparable to Bioxhale in using engineered sensor technology to enable non-invasive breath-based diagnostics.
• Deep Breath Intelligence (DBI): Switzerland-based breathomics company providing breath analysis services and biomarker discovery for clinical research and diagnostics. Directly comparable to Bioxhale in offering service-led breathomics with a research-customer focus.
• CAIRE Diagnostics (formerly Spirosure): US-based company developing FeNO breath-based diagnostics for respiratory conditions. Comparable to Bioxhale in bringing non-invasive exhaled-breath testing to clinical practice, though focused more narrowly on a single biomarker class.

Broad incumbents

• Circassia (formerly Aerocrine): UK-based respiratory diagnostics and therapeutics company that commercialized FeNO (fractional exhaled nitric oxide) testing for asthma. A broader incumbent in the respiratory diagnostics space with overlapping breath-based measurement capabilities and an established commercial channel.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/bioxhale

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BIOXHALE LTD